Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy...
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy...
TG Therapeutics (TGTX) stock crashed Monday — reversing a breakout — after missing third-quarter profit expectations, though sales of its multiple sclerosis treatment beat forecasts. ↑...
Earnings season is in full swing, and a number of stocks are making strong moves as quarterly results roll in. Financial giant JPMorgan Chase (JPM) is...
The Dow took a big hit this week, its first weekly drop in seven weeks, as nearly 30% of the index booked declines of more than...
Starboard Value took aim at Pfizer (PFE) in another blow Tuesday, saying the company has failed to deliver on what it once called the “best pipeline”...
Regeneron stock toppled Monday after a West Virginia judge unexpectedly rejected a preliminary injunction that would have prevented Amgen (AMGN) from launching a biosimilar copycat of...
Bausch + Lomb (BLCO) stock surged Monday — briefly breaking out — on a report that the company is working with advisors to explore a potential...
Merck (MRK) stock tumbled Monday after Summit Therapeutics‘ (SMMT) cancer drug outperformed blockbuster Keytruda in a study of lung cancer patients. ↑ X NOW PLAYING The...
Immunome (IMNM) stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91. ↑ X How To...
Eli Lilly (LLY) stock rose Tuesday after the drugmaker’s blockbuster weight-loss drug significantly cut the risk of developing diabetes over three years. ↑ X NOW PLAYING...
The Relative Strength (RS) Rating for PTC Therapeutics (PTCT) stock climbed into a new percentile Monday, with a rise from 80 to 83. ↑ X Stock...